by A man who was diagnosed with the most fatal form of brain cancer is clear after he has been subjected to experimental treatment.
Ben Trotman still shows no signs of glioblastoma, more than two years since he received an immunotherapy drug in a world’s first clinical study.
Most people with glioblastoma die within 12 to 18 months.
In October 2022, Mr. Trotman, 43, was diagnosed with glioblastoma. His scans are clear two years and eight months after the treatment and there are no signs of the tumor.
As a result of Mr. Trotman’s success, the NHS will try to recruit 16 people over 18 months to undergo a new immunotherapy process that is set up in honor of Baroness McDonagh, the former general secretary of the Labor Party, who has died of the illness.
The process carried out by the University College London Hospital (UCLH) follows an earlier for the same medication, which continued due to a lack of recruitment.
Dr. Paul Mulholland, the advisory medical oncologist, who treated Mr. Trotman, said: “It is very unusual to have a clear scan with Glioblastom, especially if he did not have the follow-up operation that was planned to remove the entire tumor that was originally visible to scans.
“We hope that immunotherapy and follow-up treatment that Ben has will keep his tumor in chess-and so far it has what we are happy.”
Mr. Trotman married his wife Emily two months after receiving the treatment, and in April the couple had a daughter, Mabel.
“We had a happy break”
Ms. Trotman said: “Getting this diagnosis was the most traumatic experience. We dealt with the fact that Ben had to live from seemingly completely healthy to months.
“If we had not met Dr. Mulholland, that would have been for us. We had the feeling that we had a happy break in an otherwise devastating situation.”
Lady Siobhain McDonagh, the Mitcham and Murder Members, led a fundraiser to collect more than 1 million GBP to cover the costs of the new process after the death of her sister in 2023.
Lady Siobhain said: “My beloved sister Margaret was horrified to discover that there had been no progress in the treatment of brain cancer for decades when her glioblastoma was diagnosed.
“The change of this last campaign was Margaret’s last campaign and one that I continued in her memory.”
Dr. Mulholland, who claimed that he wanted to “find a remedy for glioblastoma”, said that he was “incredibly grateful” for the support of both the baronin McDonagh and the lady Siobhain.
He said: “We take everything we have learned from previous attempts in this new study and are already planning follow-up.
The national brain appointment currently finances two jobs to support Dr. Mulholland.
In the fresh study, patients with a glioblastoma are diagnosed that immunotherapy with iPilimumab receives a medication that activates the immune system to combat cancer before undergoing standard treatment.
Patients who are interested in the study should discuss with your doctor. The treatment takes place in the UCLH clinic research facility and in the National Hospital for Neurology and Neurosurgery.
